Free Trial

Charles Schwab Investment Management Inc. Has $134.41 Million Stake in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

Charles Schwab Investment Management Inc. boosted its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 2.6% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,078 shares of the company's stock after purchasing an additional 10,030 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.68% of Molina Healthcare worth $134,405,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Integrated Investment Consultants LLC acquired a new stake in Molina Healthcare in the third quarter valued at $4,716,000. Intech Investment Management LLC lifted its position in shares of Molina Healthcare by 14.1% during the third quarter. Intech Investment Management LLC now owns 16,924 shares of the company's stock worth $5,831,000 after purchasing an additional 2,097 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Molina Healthcare during the 3rd quarter worth approximately $1,743,000. Caprock Group LLC grew its position in shares of Molina Healthcare by 3.3% in the 3rd quarter. Caprock Group LLC now owns 1,460 shares of the company's stock worth $503,000 after acquiring an additional 47 shares in the last quarter. Finally, Pathstone Holdings LLC increased its holdings in shares of Molina Healthcare by 1.1% in the 3rd quarter. Pathstone Holdings LLC now owns 6,153 shares of the company's stock valued at $2,120,000 after acquiring an additional 69 shares during the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Stock Up 2.5 %

Shares of NYSE MOH traded up $7.18 during trading hours on Monday, hitting $297.97. The stock had a trading volume of 1,244,448 shares, compared to its average volume of 544,433. The company has a market capitalization of $17.04 billion, a P/E ratio of 15.12, a P/E/G ratio of 1.00 and a beta of 0.59. Molina Healthcare, Inc. has a 52 week low of $272.69 and a 52 week high of $423.92. The firm's 50-day moving average price is $323.09 and its two-hundred day moving average price is $323.71. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 1.54.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 EPS for the quarter, beating the consensus estimate of $5.96 by $0.05. Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. The company had revenue of $10.34 billion for the quarter, compared to the consensus estimate of $9.92 billion. During the same quarter last year, the company posted $5.05 earnings per share. The company's revenue for the quarter was up 21.0% compared to the same quarter last year. Analysts anticipate that Molina Healthcare, Inc. will post 23.44 EPS for the current fiscal year.

Wall Street Analyst Weigh In

MOH has been the subject of a number of research reports. Barclays lifted their price objective on shares of Molina Healthcare from $359.00 to $372.00 and gave the stock an "equal weight" rating in a report on Friday, October 25th. StockNews.com raised shares of Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, October 18th. Wells Fargo & Company increased their price objective on shares of Molina Healthcare from $360.00 to $362.00 and gave the stock an "equal weight" rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Molina Healthcare from $354.00 to $353.00 and set a "hold" rating on the stock in a report on Monday, July 29th. Finally, Robert W. Baird lowered their target price on Molina Healthcare from $405.00 to $331.00 and set an "outperform" rating for the company in a report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, Molina Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $367.17.

View Our Latest Analysis on MOH

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Articles

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should you invest $1,000 in Molina Healthcare right now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines